Tag: managers

LEXINGTON, Ky., July 24, 2025 /PRNewswire/ -- Ramaco Resources, Inc. (NASDAQ: METC, METCB, METCL, METCZ) ("Ramaco Resources" or the "Company") announced today that it...

SKINNSKATTEBERG, Sweden, July 24, 2025 /PRNewswire/ -- Shareholders in Systemair AB (publ), reg. no. 556160-4108 ("Systemair" or the "Company") are hereby invited to attend the Company's...

WALL, N.J., July 23, 2025 /PRNewswire/ -- Student Transportation of America (STA), an industry leader in student transportation, safety, and fleet services, is pleased to...

HIGHLIGHTS RETURN TO POSITIVE COMPARABLE SALES AND TRANSACTIONS IN JUNE NEWPORT BEACH, Calif., July 23, 2025 /PRNewswire/ -- Chipotle Mexican Grill, Inc. (NYSE: CMG) today...

TORONTO, July 23, 2025 /CNW/ - Pizza Pizza Royalty Corp. (the "Company") (TSX: PZA) today announced its monthly cash dividend of $0.0775 per share for July 2025. The...

Five Nuclear Companies to Present at EnerCom Denver – The Energy Investment Conference Qualified Investors, Analysts and Energy Industry Professionals Can Register at No...

SASKATOON, SK, July 23, 2025 /CNW/ - Upcycle Minerals Inc. ("Upcycle" or the "Company") (Private) announces the official kickoff of its Brine to Potassium...

Upcoming online event to feature 15-plus speakers and world-class educational and networking opportunities, with a focus on unlocking true value in equity markets

Upcoming online event to feature 15-plus speakers and world-class educational and networking opportunities, with a focus on unlocking true value in equity markets

LEXINGTON, Ky., July 23, 2025 /PRNewswire/ -- Ramaco Resources, Inc. (NASDAQ: METC, METCB, METCL, METCZ) ("Ramaco Resources" or the "Company"), an operator and developer of...

Exploring Digital Asset Strategies to Inform Future Capital Innovation

Exploring Digital Asset Strategies to Inform Future Capital Innovation

The Flex complements the original WaveCore, which penetrates thick concrete floors and walls in the interior, to lower the cost of roof-to-indoor, building-to-building and...

ZUG, Switzerland, July 22, 2025 (GLOBE NEWSWIRE) -- Pharvaris N.V. (“Pharvaris,” Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to address unmet needs of those living with bradykinin-mediated diseases such as hereditary angioedema (HAE) and acquired angioedema due to C1 inhibitor deficiency (AAE-C1INH), announced today the pricing of an underwritten offering of (i) 8,250,000 of its ordinary shares at a price of $20.00 per share and (ii) to one investor, pre-funded warrants to purchase 500,000 ordinary shares at a price of $19.99 per pre-funded warrant, which represents the per share public offering price for the ordinary shares less the $0.01 per share exercise price for each such pre-funded warrant. All shares and pre-funded warrants in the offering are to be sold by Pharvaris. In addition, Pharvaris has granted the underwriters a 30-day option to purchase up to an additional 1,312,500 ordinary shares at the public offering price, less underwriting discounts and commissions. The gross proceeds to Pharvaris from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be approximately $175 million, excluding any exercise of the underwriters’ option to purchase additional shares. The offering is expected to close on or about July 24, 2025, subject to satisfaction of customary closing conditions.